The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine.
about
Improved Health-Related Quality of Life and Reduced Productivity Loss After Treatment With Bupropion Sustained Release: A Study in Patients With Major DepressionIs remission of depressive symptoms in primary care a realistic goal? A meta-analysisQuality of life in bipolar disorder: a review of the literatureMidline and right frontal brain function as a physiologic biomarker of remission in major depressionInternational Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.Systematic review of the neural basis of social cognition in patients with mood disorders.Treatment of chronically depressed patients: a multisite randomized controlled trial testing the effectiveness of 'Cognitive Behavioral Analysis System of Psychotherapy' (CBASP) for chronic depressions versus usual secondary care.Longitudinal Changes in Depression Symptoms and Survival Among Patients With Lung Cancer: A National Cohort Assessment.Social problem solving and depressive symptoms over time: a randomized clinical trial of cognitive-behavioral analysis system of psychotherapy, brief supportive psychotherapy, and pharmacotherapy.Augmenting antidepressant medication treatment of depressed women with emotionally focused therapy for couples: a randomized pilot study.Differential effects of sertraline in a predator exposure animal model of post-traumatic stress disorderImprovement in self-reported quality of life with cognitive therapy for recurrent major depressive disorder.Meta-analysis on the efficacy and tolerability of the augmentation of antidepressants with atypical antipsychotics in patients with major depressive disorderDeep brain stimulation for treatment-resistant depression.Deep brain stimulation of the human reward system for major depression--rationale, outcomes and outlook.From the Bench to the Trench: A Comparison of Sertraline Treatment of Major Depression in Clinical and Research Patient SamplesResidual symptoms and functioning in depression, does the type of residual symptom matter? A post-hoc analysisChange in psychosocial functioning and quality of life of patients with body dysmorphic disorder treated with fluoxetine: a placebo-controlled study.Towards achieving remission in the treatment of depression.Quality of Life in Depressed Patients in UK Primary Care: The FINDER Study.Advances in the Management of Treatment-Resistant DepressionTwelve-month, prospective, open-label study of repetitive transcranial magnetic stimulation for major depressive disorder in partial remission.Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients.Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP TrialCognitive Deficits as a Mediator of Poor Occupational Function in Remitted Major Depressive Disorder Patients.Quality of life of 'normal' controls: association with lifetime history of mental illness.Developing the evidence for evidence-based practiceThe prognostic significance of subsyndromal symptoms emerging after remission of late-life depression.The significance of treating somatic symptoms on functional outcome improvement in patients with major depressive disorder: a post hoc analysis of 2 trialsDyadic discord at baseline is associated with lack of remission in the acute treatment of chronic depressionRandomized controlled trials of serotonin-norepinephrine reuptake inhibitor in treating major depressive disorder in children and adolescents: a meta-analysis of efficacy and acceptabilityPsychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release.Exercise and pharmacotherapy in the treatment of major depressive disorder.Change in psychosocial functioning and depressive symptoms during acute-phase cognitive therapy for depression.IMPROVEMENTS IN PSYCHOSOCIAL FUNCTIONING AND HEALTH-RELATED QUALITY OF LIFE FOLLOWING EXERCISE AUGMENTATION IN PATIENTS WITH TREATMENT RESPONSE BUT NONREMITTED MAJOR DEPRESSIVE DISORDER: RESULTS FROM THE TREAD STUDY.Developing Family Relationship Competencies.Factors related to the improvement in quality of life for depressed inpatients treated with fluoxetine.Significant Need for a French Network of Expert Centers Enabling a Better Characterization and Management of Treatment-Resistant Depression (Fondation FondaMental).Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient.Healthcare professionals' perceptions on the emotional impact of having an inadequate response to antidepressant medications: survey and prospective patient audit.
P2860
Q24683006-D07BA941-81E8-4E18-AA0A-9F5340DB3DF9Q24794437-26883CDB-9915-47E8-98D7-E81D624CD9FBQ25257218-16BC707B-71BF-4413-9F68-A0A4A0899EDBQ29399995-6D11D1C8-D21C-4ED1-9976-B41F102ECA92Q30433255-3E4453F5-F264-4ADC-AD3C-9C798052687FQ30467590-75303B75-174B-4C7E-9B10-724913B1AE95Q33325739-DB24ECDB-B803-4F29-A96E-CBA348657EB4Q33816624-F4426738-0170-46CA-8738-490726655748Q33875563-205B4FBA-DA92-4190-AFB5-FF37DFDA204EQ33918503-F64697C2-2ABC-41B4-BF4F-D86721CC56F9Q33972544-A7E4A386-5262-4057-8627-7DA4783894BBQ33991058-75A9857B-2034-42FF-B4E2-C9FE34D1EBFFQ34010693-B4FABC48-1212-4700-A2F1-B8D8C56D7044Q34153354-8B07B674-DC29-4AAB-B797-E90EEF985399Q34403430-9281E132-5A03-4B58-8DDA-8440F20CE5F0Q34546238-229EB339-AE8D-4BFD-9FCA-84C236D6C9B1Q34582365-B2F94B3A-4087-49C0-9182-F186323D921FQ35095094-84E868D2-C17A-4894-A61E-158A81ADE630Q35237032-F2309601-89A9-4B38-ACC0-2312F8CE3E32Q35309316-71DAE9C7-2EB0-43E1-A5F6-58C3769B30B5Q35580600-E49D9972-1830-4AEA-91E5-F37788F07D37Q36207106-1908C6E9-1802-43D1-BB1A-680C523B4EB2Q36234571-AA74F33B-ACE0-4F63-A665-B10D59D206AAQ36439957-3176F0CC-4D52-4E67-800E-834F4444845AQ36514336-4342A553-182A-43F0-A98A-62578D0BD319Q36535169-AA9C03A2-1A78-4AB1-9095-ED846B5B3DA2Q36585273-347A4B8A-95C8-49B8-A625-E35D142E9140Q36607589-A6A3B5BE-2A9A-4C16-A413-24FA20EB2F97Q36859524-98659D7E-3E9C-45BF-BFBD-102C0506C48BQ36942348-680B0E8C-A65E-4EBA-BFFC-0E7EF39DF2DBQ36981110-1875357D-E70A-495A-8675-17BD2CB7168DQ36995148-393C07B5-1D81-487E-B911-47947131D4EEQ37243106-82F6E40D-25C1-452A-A5E6-FFEE92809F3DQ37315816-D7B44395-F256-4D4F-A7B9-3C39DDF2A0F2Q39778779-C62AB043-2015-4A73-9A55-C2F11D40B041Q39853906-C5D7B207-ABE0-4634-B346-1BCF6142BB1EQ41542075-5769B2FE-32EB-4F0E-89B9-41522374739BQ47140935-9E607B61-92EF-4D9D-A732-CBBB0855A6DAQ47599068-0A09A02E-303F-498A-9BF1-A495820516FAQ55190177-2BE19163-B8F4-44DD-85B0-768FA066CB0E
P2860
The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine.
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
The treatment of chronic depre ...... with sertraline or imipramine.
@ast
The treatment of chronic depre ...... with sertraline or imipramine.
@en
The treatment of chronic depre ...... with sertraline or imipramine.
@nl
type
label
The treatment of chronic depre ...... with sertraline or imipramine.
@ast
The treatment of chronic depre ...... with sertraline or imipramine.
@en
The treatment of chronic depre ...... with sertraline or imipramine.
@nl
prefLabel
The treatment of chronic depre ...... with sertraline or imipramine.
@ast
The treatment of chronic depre ...... with sertraline or imipramine.
@en
The treatment of chronic depre ...... with sertraline or imipramine.
@nl
P2093
P356
P1476
The treatment of chronic depre ...... with sertraline or imipramine
@en
P2093
A F Schatzberg
D S Schlager
G I Keitner
I W Miller
J C Markowitz
M B Keller
S G Kornstein
P304
P356
10.4088/JCP.V59N1108
P577
1998-11-01T00:00:00Z